Kód: 01431475
This succinct resource features the most up-to-date knowledge on myeloproliferative neoplasms, including discoveries in JAK2 and MPL mutations, groundbreaking knowledge of the FIP1L1-PDGFRA mutation, new nomenclature and classific ... celý popis
214.25 €
Potrebujete viac kusov?Ak máte záujem o viac kusov, preverte, prosím, najprv dostupnosť titulu na našej zákazníckej podpore.
Nákupom získate 530 bodov
This succinct resource features the most up-to-date knowledge on myeloproliferative neoplasms, including discoveries in JAK2 and MPL mutations, groundbreaking knowledge of the FIP1L1-PDGFRA mutation, new nomenclature and classification, revised WHO-based diagnostic criteria, novel molecular abnormalities, and therapies. International experts provide an ideal balance of new discoveries in biology and practical therapeutic strategies for these diseases. §The authors detail new understanding of genetic mutations and the impact on both the pathophysiologic and clinical contexts of myeloproliferative neoplasms. Diseases covered include essential thrombocythemia, primary and secondary myelofibrosis, hypereosinophic syndrome, chronic eosinophilic leukemia, and systemic mastocytosis. Attention is given to bone marrow findings, revised classification and WHO-based diagnostic criteria, prognostic factors, and treatment options. The full range of therapies is explored from conventional to investigational and anti-JAK2 small molecule drugs to transplant.
Zaradenie knihy Knihy po anglicky Medicine Clinical & internal medicine Diseases & disorders
214.25 €
Osobný odber Bratislava a 2642 dalších
Copyright ©2008-24 najlacnejsie-knihy.sk Všetky práva vyhradenéSúkromieCookies
Nákupný košík ( prázdny )